ArticleBMJ open2026

Development of a clinical prediction model using volatile organic compounds as breath biomarkers in squamous oesophageal neoplasms: ViSON, protocol for a multicentre case-control study in UK NHS hospitals.

Sameera Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.